Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Research » Trials

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New Diabetes Drug Galvus Matches Avandia in Control of Blood Sugars
Posted: Thursday, October 12, 2006
The new diabetes drug from Novartis, Galvus cuts blood sugar levels as much as GlaxoSmithKlines established medicine Avandia and without the side effects.

Edmonton Islet Transplants Fall Short
Posted: Thursday, October 05, 2006
The hope for a cure fails: Two years after receiving transplants of insulin-producing beta islet cells, only five of 36 patients with type 1 diabetes remained free of the need for insulin injections.

Snuff It or Puff It: Rapid Acting Insulin Nasal Spray Begins New Study
Posted: Thursday, September 28, 2006
A new pharmacokinetic study to compare Nastech's intranasal insulin to injectable insulin and Exubera(R) (insulin human [rDNA origin]) Inhalation Powder, is set to begin.

DDP-4 inhibitors: A New Class of Oral Antidiabetic Drugs – Coming Soon
Posted: Thursday, September 21, 2006
Data emerging on the safety and efficacy of the new oral antidiabetic agents were presented at the European Association for the Study of Diabetes 2006 Meeting.

MannKind Inhaled Insulin Matches Injections -Study
Posted: Thursday, September 21, 2006
An inhaled insulin being developed by MannKind Corp produces comparable improvements in blood sugar control to rapid-acting insulin analog (RAA) given by injection, researchers said on Saturday.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 2- Ramipril Arm)
Posted: Thursday, September 21, 2006
The Dream Study also found that the ACE-inhibitor Altace (ramipril) does not prevent type 2 diabetes in patients with impaired glucose metabolism.

Adherence to Preventive Medications Reduces Risk of Diabetes
Posted: Wednesday, September 13, 2006
Participants who were compliant had a 38.2% reduced risk of developing diabetes.

Weight Loss Should be the Primary Intervention for Risk of Diabetes
Posted: Thursday, August 31, 2006
In a randomized trial with 1079 participants, for over 3 years it was found that for every 2 pounds of weight loss there was a 16% reduction in risk.

Just Moderate Adiposity at Age 18 Is Associated with Twice the Risk of Premature Death
Posted: Wednesday, August 23, 2006
During 12 years of follow-up, the risk ratio was 1.66 for a BMI of 25.0 to 29.9.

New Drug Slows Diabetic Nerve Damage
Posted: Friday, July 28, 2006
The drug, epalrestat, delays the progression of diabetic peripheral neuropathy, as the condition is called, and ameliorates its symptoms.

Page 22 of 23
 |<   <<   <  17  |  18  |  19  |  20  |  21  |  22  |  23

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement